Kui Cao - Concepedia

Author

Kui Cao

Third Affiliated Hospital of Harbin Medical University ORCID

Also Known As

Cao, Kui, Kui Cao, kui cao

Publications

453

Citations

H-Index

Concepts

All Affiliations

Third Affiliated Hospital of Harbin Medical University Harbin Medical University

About

Kui Cao is an author at Third Affiliated Hospital of Harbin Medical University specializing in immunology, pathology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	66
2	Immunology	3	3	66
3	Pathology	3	3	66
4	Immunotherapy	2	2	34
5	Head And Neck Cancer	1	1	15

Kui Cao

Publications

420

Citations

H-Index

Page 1

	Year	Citations
Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis Lisha Li, Dongfeng Song, Ling Qi, Cancer Letters	2021	105
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma Jinhong Zhu, Haijiao Ao, Mingdong Liu, Journal of Translational Medicine	2021	75
Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma Kui Cao, Jinhong Zhu, Mengdi Lu, EBioMedicine	2023	44
Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer Jinhong Zhu, Yang Liu, Meng Zhao, Aging	2021	33
Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma Kui Cao, Mingdong Liu, Keru Ma, Cancer Immunology Immunotherapy Immunotherapy ResponseCancer ImmunosurveillanceMedicineLung AdenocarcinomaImmunology	2021	32
Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer Kui Cao, Tianjiao Ma, Xiaodong Ling, Annals of Translational Medicine	2021	20
Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment Kui Cao, Erliang Guo, Xionghui Mao, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceMedicineGuide TreatmentImmunologyTumor Immunity	2021	19
LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway Jianqun Ma, Kui Cao, Xiaodong Ling, Cancers	2022	19
Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma Kui Cao, Xiaodong Ling, Xiangyu Jiang, Respiratory Research	2022	19
UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma Xiaoyuan Wang, Yang Liu, Xue Leng, Pathology & Oncology Research	2021	16

Page 1